Skip to main content
HR 5782 115th Congress House

Opioid Crisis Accountability Act of 2018

Official title: To hold pharmaceutical companies accountable for illegal marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.

Introduced: May 16, 2018 See on congress.gov
Health Business ethicsBusiness expensesBusiness recordsChild health
More subjectsShow fewer subjects
Civil actions and liabilityCorporate finance and managementDepartment of Health and Human ServicesDepartment of JusticeDepartment of LaborDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesDrug, alcohol, tobacco useEducation programs fundingElementary and secondary educationEmployment taxesExecutive agency funding and structureGovernment information and archivesGovernment studies and investigationsGovernment trust fundsHealth programs administration and fundingHealth promotion and preventive careIncome tax creditsMarketing and advertisingMedical researchPreschool educationPrescription drugsResearch and developmentSecuritiesSmall businessWages and earnings
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 31, 2018
Referred to the Subcommittee on Health.
May 11, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and the Workforce, Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 11, 2018
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action May 31, 2018

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Opioid Crisis Accountability Act of 2018

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a drug manufacturer from engaging in illegal marketing and distribution practices, including falsely advertising, promoting, or marketing that an opioid has no addiction-forming or addiction-sustaining qualities or risks, supplying states or communities with a quantity of opioids that is not medically necessary, or failing to report any order or pattern of orders that would cause a reasonable person to believe the opioids were not being dispensed in a medically reasonable manner.

 Related & companion bills 1
  • S 2691 Identical bill Opioid Crisis Accountability Act of 2018
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 4
All 4 Democratic 4
D
Raskin, Jamie
Maryland · Nov 6, 2018
 D
Welch, Peter
Vermont · Nov 6, 2018
 D
Jayapal, Pramila
Washington · May 16, 2018
 D
Khanna, Ro
California · May 11, 2018
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5782: Opioid Crisis Accountability Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-5782/
MLA
"H.R. 5782: Opioid Crisis Accountability Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-5782/.
Bluebook (legal)
H.R. 5782, 115th Cong. (2026), https://openamerica.io/bill/115-HR-5782/.
Markdown link
[H.R. 5782: Opioid Crisis Accountability Act of 2018](https://openamerica.io/bill/115-HR-5782/)
Report a problem